Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10251898 Methods for treating Filoviridae virus infections

Patent 10251898 was granted and assigned to Gilead Sciences on April, 2019 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
Gilead Sciences
Gilead Sciences
0
Date Filed
February 22, 2018
0
Date of Patent
April 9, 2019
0
Patent Applicant
Gilead Sciences
Gilead Sciences
0
Patent Application Number
15902690
0
Patent Citations Received
‌
US Patent 12012431 Methods of preparing 1′-cyano nucleosides
0
‌
US Patent 11492353 Methods and compounds for treating
‌
US Patent 11701372 Inhalation formulations of 1'-cyano substituted carba-nucleoside analogs
0
‌
US Patent 11344565 Methods for the preparation of ribosides
0
‌
US Patent 11780844 Compounds and methods for treatment of viral infections
‌
US Patent 11382926 Methods for treating
‌
US Patent 11420972 Methods and compounds for treating
‌
US Patent 11851438 1′-cyano nucleoside analogs and methods for treatment of viral infections
0
‌
US Patent 11903953 Remdesivir treatment methods
0
‌
US Patent 11926645 Compounds and methods for treatment of viral infections
0
•••
Patent Inventor Names
Dustin Siegel
0
Robert Jordan
0
Adrian S. Ray
0
Byoung Kwon Chun
0
Edward Doerffler
0
Hon Chung Hui
0
Jay P. Parrish
0
Michael O'Neil Hanrahan Clarke
0
Richard L. Mackman
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10251898
0
Patent Primary Examiner
‌
Traviss C Mcintosh, III
0

Find more entities like US Patent 10251898 Methods for treating Filoviridae virus infections

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.